ANDA 71358, held by Sun Pharm Industries. Tolazamide.
As of Nov 16, 2026, ANDA 71358 (Tolazamide), held by Sun Pharm Industries, was first approved by FDA on Jul 16, 1987, with 11 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 16, 1987 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Tolazamide250MG ยท tablet;oral | Tolazamide | Discontinued |
| Sep 28, 2006 | Supplement 20Labeling | Approved | None posted |
| May 16, 2000 | Supplement 10Manufacturing | Approved | None posted |
| May 16, 2000 | Supplement 11Manufacturing | Approved | None posted |
| Dec 5, 1997 | Supplement 9Manufacturing | Approved | None posted |
| Feb 24, 1997 | Supplement 8Manufacturing | Approved | None posted |
| Jun 22, 1995 | Supplement 6Manufacturing | Approved | None posted |
| Jan 3, 1994 | Supplement 5Manufacturing | Approved | None posted |
| Aug 8, 1991 | Supplement 4Labeling | Approved | None posted |
| Aug 25, 1988 | Supplement 1Manufacturing | Approved | None posted |
| Aug 25, 1988 | Supplement 2Labeling | Approved | None posted |
| Aug 25, 1988 | Supplement 3Manufacturing | Approved | None posted |
| Jul 16, 1987 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters